File:Fig2 Smith PracLabMed2024 InPress.jpg

Original file ‎(2,764 × 3,728 pixels, file size: 450 KB, MIME type: image/jpeg)

Summary

Description	Figure 2. Responses to survey questions. Respondents were asked (a) whether they support the FDA proposal to regulate LDTs, (b) whether they perform LDTs within their laboratories, (c) if their laboratories would be negatively impacted by the proposed rule if enacted, (d) if they anticipate having to remove tests from their laboratory menus if the proposed rule is enacted, and (e) whether they have the financial resources to pay for FDA user fees. Questions for (c), (d), and (e) were asked only of respondents whose laboratories performed LDTs.
Source	Smith, Leslie; Carricaburu, Lisa A.; Genzen, Jonathan R. (2024). "The US FDA’s proposed rule on laboratory-developed tests: Impacts on clinical laboratory testing". Practical Laboratory Medicine In press: e00407. doi:10.1016/j.plabm.2024.e00407.
Date	2024
Author	Smith, Leslie; Carricaburu, Lisa A.; Genzen, Jonathan R.
Permission (Reusing this file)	Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International
Other versions